Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US62855J1043
Ticker MYGN
Company MYRIAD GENETICS
Currency $
Price
Aware Investor Index (AII) 0.2535
Recommendation HOLD
P/E 16.27
ROE 11.63 %
Capitalization 1,825,200,000 $
Dividend Yield 0.00 %
P/S 2.36
AII Position 411
P/E Position 210
ROE Position 320
Capitalization Position 636
Dividend Yield Position 594
Sales 772,600,000 $
10-Year Average Earnings 112,174,300 $
Shares Outstanding 72,000,000
Equity 964,900,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
MYRIAD GENETICS Investor Relations Web Site http://investor.myriad.com







Sales:

YEAR MONTH AMOUNT
2018 6 772,600,000.00 $
2017 6 769,900,000.00 $
2016 6 740,500,000.00 $
2015 6 722,500,000.00 $
2014 6 778,216,000.00 $
2013 6 613,165,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 6 131,100,000.00 $
2017 6 20,500,000.00 $
2016 6 117,200,000.00 $
2015 6 79,800,000.00 $
2014 6 176,225,000.00 $
2013 6 147,139,000.00 $
2012 6 112,151,000.00 $
2011 6 100,710,000.00 $
2010 6 152,303,000.00 $
2009 6 84,615,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 6 964,900,000.00 $
2017 6 768,000,000.00 $
2016 6 739,600,000.00 $
2015 6 661,700,000.00 $
2014 6 718,998,000.00 $
2013 6 728,594,000.00 $
2012 6 635,660,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 6 72,000,000
2017 6 68,800,000
2016 6 72,400,000
2015 6 74,500,000
2014 6 78,182,000
2013 6 83,327,000
2012 6 86,465,000

 












Bloomberg News for MYRIAD GENETICS:



Google News for MYRIAD GENETICS:

GlobeNewswire (press release) - 2 days ago
MYGN Loss Alert: Hagens Berman Investigating Myriad Genetics ...
SAN FRANCISCO, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the ...
PRNewswire (press release) - 4 days ago
Hagens Berman Investigating Myriad Genetics (MYGN) For Possible ...
SAN FRANCISCO, Aug. 19, 2019 /PRNewswire/ -- Hagens Berman notifies investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the firm's ...
NEWS DONE (press release) - 7 minutes ago
Investors Love This Stock?: Myriad Genetics (MYGN)
Myriad Genetics (MYGN):. In Friday trading session Myriad Genetics (MYGN) stock price ended at $22.49 by scoring a change of -2.43%.
NEWS SCANNER (press release)
Myriad Genetics Stock Has an FDA Issue
The stock of genetic testing company Myriad Genetics (MYGN) plunged 50% in two days last week, before crawling back to $25.35 by ...
About Press Release (press release)
Myriad Genetics (MYGN) Lags Q4 Earnings and Revenue Estimates
Myriad Genetics (MYGN) came out with quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.47 per share.
US Post News
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ...
... behalf of purchasers of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ:MYGN). Investors who purchased Myriad securities are ...
Barron's - 16 Aug 2019
Bragar Eagel & Squire, PC is Investigating Myriad Genetics, Inc ...
NEW YORK, Aug. 22, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C. is investigating potential claims against Myriad Genetics, Inc. (MYGN) ...
PRNewswire (press release)
How Does Myriad Genetics, Inc. (MYGN) Stack Up For Investors?
On Friday, shares of Myriad Genetics, Inc. (NASDAQ:MYGN) marked $25.35 per share versus a previous $23.20 closing price. With having a ...
Stock Muse
Myriad Genetics (MYGN): Traders Services Stock Recap:
Myriad Genetics (MYGN):. Share of Myriad Genetics (MYGN) stock price is settled at $25.35 after trading hours. Taking a look at the daily price ...
The MAK Daily
Myriad Genetics Inc (MYGN) Q4 2019 Earnings Call Transcript
Good afternoon, and welcome to the Myriad Genetics fiscal fourth quarter 2019 earnings call. My name is Scott Gleason, and I'm the Head of ...


Back